To assess six-month antibody kinetics and durability after three doses of SARS-CoV-2 vaccine in solid organ transplant recipients
Latest Information Update: 02 Aug 2022
At a glance
- Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 02 Aug 2022 New trial record
- 08 Jun 2022 Results presented at the 2022 American Transplant Congress